Skip to main content
Erschienen in: Journal of Cancer Survivorship 3/2016

11.12.2015

Medicaid expansion and access to care among cancer survivors: a baseline overview

verfasst von: Wafa W. Tarazi, Cathy J. Bradley, David W. Harless, Harry D. Bear, Lindsay M. Sabik

Erschienen in: Journal of Cancer Survivorship | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Medicaid expansion under the Affordable Care Act facilitates access to care among vulnerable populations, but 21 states have not yet expanded the program. Medicaid expansions may provide increased access to care for cancer survivors, a growing population with chronic conditions. We compare access to health care services among cancer survivors living in non-expansion states to those living in expansion states, prior to Medicaid expansion under the Affordable Care Act.

Methods

We use the 2012 and 2013 Behavioral Risk Factor Surveillance System to estimate multiple logistic regression models to compare inability to see a doctor because of cost, having a personal doctor, and receiving an annual checkup in the past year between cancer survivors who lived in non-expansion states and survivors who lived in expansion states.

Results

Cancer survivors in non-expansion states had statistically significantly lower odds of having a personal doctor (adjusted odds ratio [AOR] 0.76, 95 % confidence interval [CI] 0.63–0.92, p < 0.05) and higher odds of being unable to see a doctor because of cost (AOR 1.14, 95 % CI 0.98–1.31, p < 0.10). Statistically significant differences were not found for annual checkups.

Conclusions

Prior to the passage of the Affordable Care Act, cancer survivors living in expansion states had better access to care than survivors living in non-expansion states. Failure to expand Medicaid could potentially leave many cancer survivors with limited access to routine care.

Implications for Cancer Survivors

Existing disparities in access to care are likely to widen between cancer survivors in Medicaid non-expansion and expansion states.
Literatur
3.
Zurück zum Zitat Erikson C, Salsberg E, Forte G, Bruinooge S, Goldstein M. Future supply and demand for oncologists: challenges to assuring access to oncology services. J Oncol Pract. 2007;3:79–86.CrossRefPubMedPubMedCentral Erikson C, Salsberg E, Forte G, Bruinooge S, Goldstein M. Future supply and demand for oncologists: challenges to assuring access to oncology services. J Oncol Pract. 2007;3:79–86.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat McCabe MS, Jacobs LA. Clinical update: survivorship care—models and programs. Semin Oncol Nurs. 2012;28:e1–8.CrossRefPubMed McCabe MS, Jacobs LA. Clinical update: survivorship care—models and programs. Semin Oncol Nurs. 2012;28:e1–8.CrossRefPubMed
5.
Zurück zum Zitat Earle CC. Failing to plan is planning to fail: improving the quality of care with survivorship care plans. J Clin Oncol Off J Am Soc Clin Oncol. 2006;24:5112–6.CrossRef Earle CC. Failing to plan is planning to fail: improving the quality of care with survivorship care plans. J Clin Oncol Off J Am Soc Clin Oncol. 2006;24:5112–6.CrossRef
6.
Zurück zum Zitat Mayer EL, Gropper AB, Neville BA, Partridge AH, Cameron DB, Winer EP, et al. Breast cancer survivors’ perceptions of survivorship care options. J Clin Oncol. 2012;30:158–63.CrossRefPubMed Mayer EL, Gropper AB, Neville BA, Partridge AH, Cameron DB, Winer EP, et al. Breast cancer survivors’ perceptions of survivorship care options. J Clin Oncol. 2012;30:158–63.CrossRefPubMed
7.
Zurück zum Zitat Earle CC, Burstein HJ, Winer EP, Weeks JC. Quality of non-breast cancer health maintenance among elderly breast cancer survivors. J Clin Oncol Off J Am Soc Clin Oncol. 2003;21:1447–51.CrossRef Earle CC, Burstein HJ, Winer EP, Weeks JC. Quality of non-breast cancer health maintenance among elderly breast cancer survivors. J Clin Oncol Off J Am Soc Clin Oncol. 2003;21:1447–51.CrossRef
8.
Zurück zum Zitat Yabroff RK, Short PF, Machlin S, Dowling E, Rozjabek H, Li C, et al. Access to preventive health care for cancer survivors. Am J Prev Med. 2013;45:304–12.CrossRefPubMedCentral Yabroff RK, Short PF, Machlin S, Dowling E, Rozjabek H, Li C, et al. Access to preventive health care for cancer survivors. Am J Prev Med. 2013;45:304–12.CrossRefPubMedCentral
9.
Zurück zum Zitat Kent EE, Forsythe LP, Yabroff KR, Weaver KE, Moor JS, Rodriguez JL, et al. Are survivors who report cancer‐related financial problems more likely to forgo or delay medical care? Cancer. 2013;119:3710–7.CrossRefPubMedPubMedCentral Kent EE, Forsythe LP, Yabroff KR, Weaver KE, Moor JS, Rodriguez JL, et al. Are survivors who report cancer‐related financial problems more likely to forgo or delay medical care? Cancer. 2013;119:3710–7.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Weaver KE, Rowland JH, Bellizzi KM, Aziz NM. Forgoing medical care because of cost: assessing disparities in healthcare access among cancer survivors living in the United States. Cancer. 2010;116:3493–504.CrossRefPubMedPubMedCentral Weaver KE, Rowland JH, Bellizzi KM, Aziz NM. Forgoing medical care because of cost: assessing disparities in healthcare access among cancer survivors living in the United States. Cancer. 2010;116:3493–504.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Earle CC, Neville BA. Under use of necessary care among cancer survivors. Cancer. 2004;101:1712–9.CrossRefPubMed Earle CC, Neville BA. Under use of necessary care among cancer survivors. Cancer. 2004;101:1712–9.CrossRefPubMed
14.
Zurück zum Zitat Dulko D, Pace CM, Dittus KL, Sprague BL, Pollack LA, Hawkins NA, et al. Barriers and facilitators to implementing cancer survivorship care plans. Oncol Nurs Forum. 2013;40:575–80.CrossRefPubMedPubMedCentral Dulko D, Pace CM, Dittus KL, Sprague BL, Pollack LA, Hawkins NA, et al. Barriers and facilitators to implementing cancer survivorship care plans. Oncol Nurs Forum. 2013;40:575–80.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Steinberg ML. Inequity in cancer care: explanations and solutions for disparity. Semin Radiat Oncol. 2008;18:161–7.CrossRefPubMed Steinberg ML. Inequity in cancer care: explanations and solutions for disparity. Semin Radiat Oncol. 2008;18:161–7.CrossRefPubMed
16.
Zurück zum Zitat Pisu M, Martin MY, Shewchuk R, Meneses K. Dealing with the financial burden of cancer: perspectives of older breast cancer survivors. Support Care Cancer. 2014;22:3045–52.CrossRefPubMedPubMedCentral Pisu M, Martin MY, Shewchuk R, Meneses K. Dealing with the financial burden of cancer: perspectives of older breast cancer survivors. Support Care Cancer. 2014;22:3045–52.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Antos J. The Medicaid expansion is not such a good deal for states or the poor. J Health Polit Policy Law. 2013;38:179–86.CrossRefPubMed Antos J. The Medicaid expansion is not such a good deal for states or the poor. J Health Polit Policy Law. 2013;38:179–86.CrossRefPubMed
22.
Zurück zum Zitat Coughlin TA, Long SK, Shen Y. Assessing access to care under Medicaid: evidence for the nation and thirteen states. Health Aff. 2005;24:1073–83.CrossRef Coughlin TA, Long SK, Shen Y. Assessing access to care under Medicaid: evidence for the nation and thirteen states. Health Aff. 2005;24:1073–83.CrossRef
24.
Zurück zum Zitat Sommers BD, Baicker K, Epstein AM. Mortality and access to care among adults after state Medicaid expansions. N Engl J Med. 2012;367:1025–34.CrossRefPubMed Sommers BD, Baicker K, Epstein AM. Mortality and access to care among adults after state Medicaid expansions. N Engl J Med. 2012;367:1025–34.CrossRefPubMed
27.
Zurück zum Zitat Horning SJ. Follow-up of adult cancer survivors: new paradigms for survivorship care planning. Hematol Oncol Clin North Am. 2008;22:201–10.CrossRefPubMed Horning SJ. Follow-up of adult cancer survivors: new paradigms for survivorship care planning. Hematol Oncol Clin North Am. 2008;22:201–10.CrossRefPubMed
28.
Zurück zum Zitat Balogh EP, Ganz PA, Murphy SB, Nass SJ, Ferrell BR, Stovall E. Patient-centered cancer treatment planning: improving the quality of oncology care. Summary of an Institute of Medicine Workshop. Oncologist. 2011;16:1800–5.CrossRefPubMedPubMedCentral Balogh EP, Ganz PA, Murphy SB, Nass SJ, Ferrell BR, Stovall E. Patient-centered cancer treatment planning: improving the quality of oncology care. Summary of an Institute of Medicine Workshop. Oncologist. 2011;16:1800–5.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Khan NF, Evans J, Rose PW. A qualitative study of unmet needs and interactions with primary care among cancer survivors. Br J Cancer. 2011;105:S46–51.CrossRefPubMedPubMedCentral Khan NF, Evans J, Rose PW. A qualitative study of unmet needs and interactions with primary care among cancer survivors. Br J Cancer. 2011;105:S46–51.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Friese C, Martinez K, Abrahamse P, Hamilton A, Graff J, Jagsi R, et al. Providers of follow-up care in a population-based sample of breast cancer survivors. Breast Cancer Res Treat. 2014;144:179–84.CrossRefPubMedPubMedCentral Friese C, Martinez K, Abrahamse P, Hamilton A, Graff J, Jagsi R, et al. Providers of follow-up care in a population-based sample of breast cancer survivors. Breast Cancer Res Treat. 2014;144:179–84.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Miedema B, Easley J. Barriers to rehabilitative care for young breast cancer survivors: a qualitative understanding. Support Care Cancer. 2012;20:1193–201.CrossRefPubMed Miedema B, Easley J. Barriers to rehabilitative care for young breast cancer survivors: a qualitative understanding. Support Care Cancer. 2012;20:1193–201.CrossRefPubMed
38.
Zurück zum Zitat Hong S, Nekhlyudov L, Didwania A, Olopade O, Ganschow P. Cancer survivorship care: exploring the role of the general internist. J Gen Intern Med. 2009;24:495–500.CrossRefPubMedCentral Hong S, Nekhlyudov L, Didwania A, Olopade O, Ganschow P. Cancer survivorship care: exploring the role of the general internist. J Gen Intern Med. 2009;24:495–500.CrossRefPubMedCentral
39.
Zurück zum Zitat Ng AK, Travis LB. Second primary cancers: an overview. Hematol Oncol Clin North Am. 2008;22:271–89.CrossRefPubMed Ng AK, Travis LB. Second primary cancers: an overview. Hematol Oncol Clin North Am. 2008;22:271–89.CrossRefPubMed
42.
Zurück zum Zitat Weissman JS, Zaslavsky AM, Wolf RE, Ayanian JZ. State Medicaid coverage and access to care for low-income adults. J Health Care Poor Underserved. 2008;19:307–19.CrossRefPubMed Weissman JS, Zaslavsky AM, Wolf RE, Ayanian JZ. State Medicaid coverage and access to care for low-income adults. J Health Care Poor Underserved. 2008;19:307–19.CrossRefPubMed
43.
Zurück zum Zitat Adams EK, Kenney GM, Galactionova K. Preventive and reproductive health services for women: the role of California’s family planning waiver. Am J Health Promot. 2013;27:1–10.CrossRef Adams EK, Kenney GM, Galactionova K. Preventive and reproductive health services for women: the role of California’s family planning waiver. Am J Health Promot. 2013;27:1–10.CrossRef
Metadaten
Titel
Medicaid expansion and access to care among cancer survivors: a baseline overview
verfasst von
Wafa W. Tarazi
Cathy J. Bradley
David W. Harless
Harry D. Bear
Lindsay M. Sabik
Publikationsdatum
11.12.2015
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 3/2016
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-015-0504-5

Weitere Artikel der Ausgabe 3/2016

Journal of Cancer Survivorship 3/2016 Zur Ausgabe

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.